| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/30/2003 | US20030022317 Use of site-specific nicking endonucleases to create single-stranded regions and applications thereof |
| 01/30/2003 | US20030022316 Polypeptide for use in the diagnostic, therapeutic treatment of cell proliferation defects |
| 01/30/2003 | US20030022314 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 01/30/2003 | US20030022313 Novel neuronal cell growth factor |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022305 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides |
| 01/30/2003 | US20030022303 Expression vector for use in the treatment of blood disorders |
| 01/30/2003 | US20030022302 Toll-like receptor |
| 01/30/2003 | US20030022291 Production of a multimeric protein by cell fusion method |
| 01/30/2003 | US20030022290 Method for modulating processes mediated by farnesoid activated receptors |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022287 Non aggregating fluorescent proteins and methods for using the same |
| 01/30/2003 | US20030022286 Novel transporter-like genes and uses therefor |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022281 Kluyveromyces lactis maltase/maltose permease bi-directional promoter and use thereof |
| 01/30/2003 | US20030022280 Compositions and methods for producing high yields of heterologous polypeptides in a pichia cell |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022276 Dendritic enriched secreted lymphocyte activation molecule |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022273 Fermentative carotenoid production |
| 01/30/2003 | US20030022269 Monitoring chemotaxis of cells; obtain cells, insert into container, expose to substrate, monitor migration of cells |
| 01/30/2003 | US20030022265 Plasmid coding preferential enzymatic polypetide for use in the evaluation enzyme substrates |
| 01/30/2003 | US20030022257 Nucleotide sequences coding polypeptid for use in the diagnosis and prevention of lung cancer |
| 01/30/2003 | US20030022254 Protein for use in the classification, diagnosis, evaluation and treatment of cell proliferative, skin, urogenital, brain and gastrointestinal disorders |
| 01/30/2003 | US20030022241 Detection of modulators of enzyme activity; obtain sample containing kinase activity, incubate with modulator, monitor diabetic response |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
| 01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022230 Molecule assigning genotype to phenotype and use thereof |
| 01/30/2003 | US20030022227 Hybridization substrate for use in genome analysis and bacterial detection |
| 01/30/2003 | US20030022225 Releasable nonvolatile mass-label molecules |
| 01/30/2003 | US20030022221 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022218 Detection of transformed cells; obtain vector, expose to cells, transform, propagating cells, detect reporter molecules, separate cell expressing reporter molecules, propagate cells |
| 01/30/2003 | US20030022213 Method for producing diverse libraries of encoded polypeptides |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022210 Induction of tissue repair and/or regeneration; obtain cells, incubate with lymphocytes, monitor regeneration of tissues |
| 01/30/2003 | US20030022209 ADSLs as modifiers of the p53 pathway and methods of use |
| 01/30/2003 | US20030022199 Transporter genes OATP-B,C,D, and E |
| 01/30/2003 | US20030022197 Device for monitoring haptotaxis |
| 01/30/2003 | US20030022196 Methods and compositions for screening for altered cellular phenotypes |
| 01/30/2003 | US20030022195 59914 and 59921, choline transporters and uses therefor |
| 01/30/2003 | US20030022193 Method for purification and subsequent determination of double-strand DNA |
| 01/30/2003 | US20030022192 Geenration of nucleotide sequences library; obtain nucleotide sequences, incubate with vector, digest, ligate, recover and vector with nucleotide sequence insertion, transform cells with vector, propagate cells, recover library |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022185 Secreted protein HLHFP03 |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022179 Methods and reagents for molecular cloning |
| 01/30/2003 | US20030022178 Identification of sortase gene |
| 01/30/2003 | US20030022177 Single-labeled oligonucleotide probes for homogeneous nucleic acid sequence analysis |
| 01/30/2003 | US20030022172 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 01/30/2003 | US20030022159 Method for identifying intercellular protein factors |
| 01/30/2003 | US20030022157 Methods of producing a library and methods of selecting polynucleotides of interest |
| 01/30/2003 | US20030022156 Transducing Phages |
| 01/30/2003 | US20030021813 Essential bacteria genes and genome scanning in Haemophilus influenzae for the identification of 'essential genes' |
| 01/30/2003 | US20030021812 Genetic engineering; vaccines; induction immunology response, antibodies |
| 01/30/2003 | US20030021811 Modulating production of pneumococcal capsular polysaccharide |
| 01/30/2003 | US20030021807 Prevent lentivirus infections; polypeptides |
| 01/30/2003 | US20030021805 Generation of HCV-like particles and chimeric HCV virus |
| 01/30/2003 | US20030021803 Transgenic plant-based vaccines |
| 01/30/2003 | US20030021796 Method of enhancing T cell immunity by selection of antigen specific T cells |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021792 Quantitative analysis; immunosuppressants, anticoagulants |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021785 Use of rank antagonists to treat cancer |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021776 Regulation of angiogenesis with zinc finger proteins |
| 01/30/2003 | US20030021771 Osteoblast precursors from human embryonic stem cells |
| 01/30/2003 | US20030021769 Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/30/2003 | US20030021766 Nucleic acid mucosal immunization |
| 01/30/2003 | CA2492007A1 Amplification of nucleic acid fragments using nicking agents |
| 01/30/2003 | CA2491995A1 Exponential nucleic acid amplification using nicking endonucleases |
| 01/30/2003 | CA2486593A1 Regulation of peroxisomal fatty acid transport in plants |
| 01/30/2003 | CA2454573A1 Protein and nucleic acid expression systems |
| 01/30/2003 | CA2454566A1 Phenylthiocarbamide (ptc) taste receptor |
| 01/30/2003 | CA2454563A1 Glucans and glucansucrases derived from lactic acid bacteria |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454423A1 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
| 01/30/2003 | CA2454307A1 Human type antihuman ige receptor antibody and antibody fragment |
| 01/30/2003 | CA2454248A1 Methods of creating genetic diversity |
| 01/30/2003 | CA2454185A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | CA2454119A1 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453663A1 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 01/30/2003 | CA2453662A1 Modification of human variable domains |
| 01/30/2003 | CA2453428A1 Plant ion channels and methods |
| 01/30/2003 | CA2453366A1 Methods, apparatus, and computer programs for verifying the integrity of a probe |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452653A1 Silencing of gene expression by sirna |
| 01/30/2003 | CA2452518A1 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | CA2452421A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | CA2451607A1 A thermostable isomerase and use thereof in particular for producing tagatose |
| 01/30/2003 | CA2450692A1 Tumor antigen |
| 01/30/2003 | CA2450343A1 Thermal cycling system and method of use |